DORETA PROLONG
75MG/650MG TBL PRO 30 II
| SPC - Summary of product characteristics | doreta-prolong-spc.pdf |
|---|---|
| NR - Registration decision | NR20268614.pdf |
| PIL - Package leaflet | doreta-prolong-pil.pdf |
| PAR - Public assessment report | |
| Text on the wrap | doreta-prolong-obal.pdf |
| Braills | Approved – name of the medicinal product in Braille on the packaging was confirmed. |
cz